{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:45:47Z","timestamp":1782877547804,"version":"3.54.5"},"reference-count":179,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Diabetic cardiomyopathy (DCM) is a diabetes-induced heart condition characterized by ventricular dysfunction without other cardiac diseases. Chronic hyperglycemia, insulin resistance, and metabolic disturbances drive myocardial damage through renin\u2013angiotensin\u2013aldosterone system (RAAS) activation, oxidative stress, mitochondrial dysfunction, advanced glycation end product (AGE) accumulation, and persistent inflammation. The COVID-19 pandemic, caused by SARS-CoV-2, has intensified cardiovascular risk in diabetic patients. The virus uses ACE2 receptors, abundant in the heart and other organs, enabling multi-organ injury. COVID-19 may worsen glucose control or induce new-onset diabetes via pancreatic injury, insulin resistance, and stress hyperglycemia. Pre-existing diabetes increases the risk of severe COVID-19, cytokine storms, endothelial dysfunction, and thrombosis. In combination, both conditions promote RAAS imbalance, exaggerated inflammation, and hypercoagulability, amplifying myocardial injury, fibrosis, and heart failure risk. This review highlights the intricate bidirectional relationship between DCM and COVID-19, emphasizing shared pathogenic mechanisms such as RAAS dysregulation, endothelial damage, cytokine overproduction, and coagulopathy. Understanding these overlapping pathways is crucial for developing effective preventive and therapeutic strategies to mitigate adverse outcomes in this vulnerable population.<\/jats:p>","DOI":"10.3389\/fphar.2025.1683159","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:17:43Z","timestamp":1760329063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk"],"prefix":"10.3389","volume":"16","author":[{"given":"Swati","family":"Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shradha","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/jama.2022.2411","article-title":"The COVID heart-one year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks","volume":"327","author":"Abbasi","year":"2022","journal-title":"Jama"},{"key":"B2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.phymed.2018.04.039","article-title":"The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats","volume":"43","author":"Abdel-Mageid","year":"2018","journal-title":"Phytomedicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.3390\/cells9112528","article-title":"The potential role of osteopontin and furin in worsening disease outcomes in COVID-19 patients with pre-existing diabetes","volume":"9","author":"Adu-Agyeiwaah","year":"2020","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"201475","DOI":"10.1155\/2013\/201475","article-title":"Role of the eNOS-NO system in regulating the antiproteinuric effects of VEGF receptor 2 inhibition in diabetes","volume":"2013","author":"Advani","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.3390\/ijms22063170","article-title":"PAI-1 in diabetes: pathophysiology and role as a therapeutic target","volume":"22","author":"Altalhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/s2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.dsx.2020.04.013","article-title":"Diabetes self-management amid COVID-19 pandemic","volume":"14","author":"Banerjee","year":"2020","journal-title":"Diabetes Metab. Syndr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"lancet Diabetes Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"103215","DOI":"10.1016\/j.ebiom.2021.103215","article-title":"Direct or indirect endothelial damage? An unresolved question","volume":"64","author":"Basta","year":"2021","journal-title":"EBioMedicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.arteri.2023.12.004","article-title":"Thrombotic risk assessed by PAI-1 in patients with COVID-19: the influence of hyperglycemia and diabetes mellitus","volume":"36","author":"Basurto","year":"2024","journal-title":"Clin. Investig. Arterioscler."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3390\/life13071598","article-title":"The role of renin-angiotensin system in diabetic cardiomyopathy: a narrative review","volume":"13","author":"Batista","year":"2023","journal-title":"Life (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e002424","DOI":"10.1161\/circheartfailure.115.002424","article-title":"Chronic Co-Administration of sepiapterin and L-Citrulline ameliorates diabetic cardiomyopathy and myocardial ischemia\/reperfusion injury in Obese type 2 diabetic mice","volume":"9","author":"Baumgardt","year":"2016","journal-title":"Circ. Heart Fail"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/art.40071","article-title":"Review: cytokine storm syndrome: looking toward the precision medicine era","volume":"69","author":"Behrens","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-Immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1177\/1932296820924469","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","volume":"14","author":"Bode","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/s2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e12757","DOI":"10.1111\/micc.12757","article-title":"Coronary microvascular dysfunction is common in patients hospitalized with COVID-19 infection","volume":"29","author":"\u00c7al\u0131\u015fkan","year":"2022","journal-title":"Microcirculation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1210\/edrv.22.1.0417","article-title":"Diabetes and endothelial dysfunction: a clinical perspective","volume":"22","author":"Calles-Escandon","year":"2001","journal-title":"Endocr. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/dc17-2131","article-title":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study","volume":"41","author":"Carey","year":"2018","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"605908","DOI":"10.3389\/fphys.2020.605908","article-title":"SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress","volume":"11","author":"Chang","year":"2021","journal-title":"Front. Physiology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.2147\/dmso.S244432","article-title":"Integrated datasets of proteomic and metabolomic biomarkers to predict its impacts on comorbidities of type 2 diabetes mellitus","volume":"13","author":"Cheema","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14336\/ad.2021.0704","article-title":"Coagulation disorders and thrombosis in COVID-19 patients and a possible mechanism involving endothelial cells: a review","volume":"13","author":"Chen","year":"2022","journal-title":"Aging Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1162754","DOI":"10.3389\/fendo.2023.1162754","article-title":"Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/atvbaha.115.306774","article-title":"Cardiomyocyte VEGF regulates endothelial cell GPIHBP1 to relocate lipoprotein lipase to the coronary lumen during diabetes mellitus","volume":"36","author":"Chiu","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"176969","DOI":"10.1016\/j.ejphar.2024.176969","article-title":"Nanomedicine: a great boon for cardiac regenerative medicine","volume":"982","author":"Choudhury","year":"","journal-title":"Eur. J. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1497352","DOI":"10.3389\/fendo.2024.1497352","article-title":"Editorial: the complex phenotype of diabetic cardiomyopathy: clinical indicators and novel treatment targets","volume":"15","author":"Choudhury","year":"","journal-title":"Front. Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"8155","DOI":"10.3390\/ijms25158155","article-title":"Comprehensive review of COVID-19: Epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and post-pandemic treatment strategies","volume":"25","author":"Chung","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"dmm052086","DOI":"10.1242\/dmm.052086","article-title":"Translating animal models of SARS-CoV-2 infection to vascular, neurological and gastrointestinal manifestations of COVID-19","volume":"18","author":"Chung","year":"2025","journal-title":"Dis. Models Mech."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7527953","DOI":"10.1155\/2020\/7527953","article-title":"Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment","volume":"2020","author":"Cicco","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e13463","DOI":"10.1111\/eci.13463","article-title":"Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: diabetes and obesity as possible enhancer","volume":"51","author":"Couselo-Seijas","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12931-023-02650-9","article-title":"What is the actual relationship between neutrophil extracellular traps and COVID-19 severity? A longitudinal study","volume":"25","author":"de Diego","year":"2024","journal-title":"Respir. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.31083\/j.rcm.2020.03.78","article-title":"SARS-CoV-2 infection in patients with diabetes mellitus and hypertension: a systematic review","volume":"21","author":"Deravi","year":"2020","journal-title":"RCM"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e39996","DOI":"10.1016\/j.heliyon.2024.e39996","article-title":"Mechanistic insights and therapeutic potential of astilbin and apigenin in diabetic cardiomyopathy","volume":"10","author":"Dhiman","year":"2024","journal-title":"Heliyon"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/s41467-021-22781-1","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection","volume":"12","author":"Diao","year":"2021","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"15667","DOI":"10.1038\/s41598-021-95277-z","article-title":"A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients","volume":"11","author":"Drakos","year":"2021","journal-title":"Sci. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2174\/1566524053766059","article-title":"Type 2 diabetes: an atherothrombotic syndrome","volume":"5","author":"Dunn","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-021-01286-7","article-title":"Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte","volume":"20","author":"D\u2019Onofrio","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e9438","DOI":"10.7759\/cureus.9438","article-title":"A review of postmortem findings in patients with COVID-19","volume":"12","author":"Eketunde","year":"2020","journal-title":"Cureus"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41366-022-01136-w","article-title":"ACE2 expression in adipose tissue is associated with cardio-metabolic risk factors and cell type composition\u2014implications for COVID-19","volume":"46","author":"El-Sayed Moustafa","year":"2022","journal-title":"Int. J. Obes."},{"key":"B43","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/pathogens10060692","article-title":"Description and analysis of cytokine storm in registered COVID-19 clinical trials: a systematic review","volume":"10","author":"Eljaaly","year":"2021","journal-title":"Pathogens"},{"key":"B44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11906-004-0081-x","article-title":"Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus","volume":"6","author":"Endemann","year":"2004","journal-title":"Curr. Hypertens. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"112563","DOI":"10.1016\/j.biopha.2021.112563","article-title":"AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation","volume":"146","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.1101\/2020.03.27.20045427","volume-title":"The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes","author":"Feng","year":"2020"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1001\/jama.2020.17445","article-title":"COVID-19 and heart failure with preserved ejection fraction","volume":"324","author":"Freaney","year":"2020","journal-title":"Jama"},{"key":"B48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41420-024-02044-w","article-title":"Regulation of cardiac ferroptosis in diabetic human heart failure: uncovering molecular pathways and key targets","volume":"10","author":"Gawargi","year":"2024","journal-title":"Cell Death Discov."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6555","DOI":"10.3390\/ijerph19116555","article-title":"Increased risk of COVID-19 in patients with diabetes mellitus-current challenges in pathophysiology, treatment and prevention","volume":"19","author":"G\u0119ca","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B50","doi-asserted-by":"publisher","first-page":"14876","DOI":"10.3390\/ijms241914876","article-title":"COVID-19 complications: oxidative stress, inflammation, and mitochondrial and endothelial dysfunction","volume":"24","author":"Georgieva","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/circresaha.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/circresaha.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2337\/dc20-2260","article-title":"COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes","volume":"44","author":"Gregory","year":"2021","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1172\/jci114142","article-title":"Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance","volume":"84","author":"Groop","year":"1989","journal-title":"J. Clin. Invest."},{"key":"B56","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.3390\/ijms24108867","article-title":"Antiviral therapy of COVID-19","volume":"24","author":"Gudima","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e3319","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"36","author":"Guo","year":"2020","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s40200-021-00777-4","article-title":"Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Hariyanto","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"key":"B59","doi-asserted-by":"publisher","first-page":"173376","DOI":"10.1016\/j.ejphar.2020.173376","article-title":"Role of AMP-activated protein kinase on cardio-metabolic abnormalities in the development of diabetic cardiomyopathy: a molecular landscape","volume":"888","author":"Haye","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"6612063","DOI":"10.1155\/2021\/6612063","article-title":"Nanotechnology in the treatment of diabetic complications: a comprehensive narrative review","volume":"2021","author":"He","year":"2021","journal-title":"J. Diabetes Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"706185","DOI":"10.3389\/fphys.2021.706185","article-title":"Diabetes, heart failure, and COVID-19: an update","volume":"12","author":"Hebbard","year":"2021","journal-title":"Front. Physiology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1306290","DOI":"10.3389\/fendo.2023.1306290","article-title":"Interactions between COVID-19 infection and diabetes","volume":"14","author":"Heshmati","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00125-021-05637-7","article-title":"Metabolic, structural and biochemical changes in diabetes and the development of heart failure","volume":"65","author":"Ho","year":"2022","journal-title":"Diabetologia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1751-7176.2011.00449.x","article-title":"Renin-Angiotensin-aldosterone system in diabetes and hypertension","volume":"13","author":"Hsueh","year":"2011","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/cphy.c160021","article-title":"Pathophysiological fundamentals of diabetic cardiomyopathy","volume":"7","author":"Hu","year":"2017","journal-title":"Compr. Physiol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/life15050726","article-title":"COVID-19 and diabetes: persistent cardiovascular and renal risks in the post-pandemic landscape","volume":"15","author":"Huang","year":"2025","journal-title":"Life"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s12325-025-03185-9","article-title":"Diabetes mellitus and associated vascular disease: pathogenesis, complications, and evolving treatments","volume":"42","author":"Islam","year":"2025","journal-title":"Adv. Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/dom.14329","article-title":"Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2","volume":"23","author":"Israelsen","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"B73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jdiacomp.2006.02.001","article-title":"High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro","volume":"21","author":"Iwasaki","year":"2007","journal-title":"J. Diabetes Complicat."},{"key":"B74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circulation Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"602735","DOI":"10.3389\/fendo.2021.602735","article-title":"Severity of COVID-19 and treatment strategy for patient with diabetes","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fcvm.2020.00012","article-title":"Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy","volume":"7","author":"Kaludercic","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"100147","DOI":"10.1016\/j.imj.2024.100147","article-title":"Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions","volume":"3","author":"Kamdar","year":"2024","journal-title":"Infect. Med. (Beijing)"},{"key":"B79","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/s2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/s2213-8587(24)00218-3","article-title":"Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial","volume":"12","author":"Kosiborod","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1089\/ars.2007.2013","article-title":"Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities","volume":"10","author":"Le Brocq","year":"2008","journal-title":"Antioxid. Redox Signal"},{"key":"B82","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/ehjcvp\/pvad067","article-title":"Effects of renin-angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Lee","year":"2024","journal-title":"Eur. Heart J. Cardiovasc Pharmacother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/s2213-2600(20)30404-5","article-title":"Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes","volume":"8","author":"Leisman","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/dom.14057","article-title":"COVID-19 infection may cause ketosis and ketoacidosis","volume":"22","author":"Li","year":"","journal-title":"Diabetes Obes. Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"","journal-title":"J. Allergy Clin. Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.3390\/jcm10112419","article-title":"Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis","volume":"10","author":"Li","year":"2021","journal-title":"J. Clin. Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2147\/dmso.S454408","article-title":"New insights into the effects of SARS-CoV-2 on metabolic organs: a narrative review of COVID-19 induced diabetes","volume":"17","author":"Li","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"B89","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: from pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1431292","DOI":"10.3389\/fendo.2024.1431292","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e2102466","DOI":"10.1002\/advs.202102466","article-title":"Emerging theranostic nanomaterials in diabetes and its complications","volume":"9","author":"Liu","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose Co-Transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"ar147","DOI":"10.1091\/mbc.E22-02-0045","article-title":"SARS-CoV-2 down-regulates ACE2 through lysosomal degradation","volume":"33","author":"Lu","year":"2022","journal-title":"Mol. Biol. Cell"},{"key":"B94","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/cvr\/cvad191","article-title":"SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?","volume":"120","author":"Lui","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"B95","unstructured":"Study on the effect of alginate disodium nanoparticles on vascular endothelial function in diabetic cardiomyopathy rats\n          \n          \n            \n              Luyan\n              Y.\n            \n          \n          China: Qingdao University\n          \n          2018"},{"key":"B96","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.yjmcc.2021.11.010","article-title":"Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications","volume":"164","author":"Ma","year":"2022","journal-title":"J. Mol. Cell Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tem.2013.08.002","article-title":"Unlocking the biology of RAGE in diabetic microvascular complications","volume":"25","author":"Manigrasso","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00592-020-01570-0","article-title":"Type 1 diabetes onset triggered by COVID-19","volume":"57","author":"Marchand","year":"2020","journal-title":"Acta Diabetol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"","journal-title":"N. Engl. J. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"","journal-title":"N. Engl. J. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"921452","DOI":"10.3389\/fmed.2022.921452","article-title":"Immunomodulatory therapies for COVID-19","volume":"9","author":"Mathur","year":"2022","journal-title":"Front. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B103","doi-asserted-by":"publisher","first-page":"167726","DOI":"10.1016\/j.bbadis.2025.167726","article-title":"Pathogenesis and therapeutic effect of sitagliptin in experimental diabetic model of COVID-19","volume":"1871","author":"Meng","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report","volume":"158","author":"Moores","year":"2020","journal-title":"Chest"},{"key":"B106","doi-asserted-by":"publisher","first-page":"E736","DOI":"10.1152\/ajpendo.00124.2020","article-title":"COVID-19 pandemic, coronaviruses, and diabetes mellitus","volume":"318","author":"Muniyappa","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1056\/NEJMc1712572","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12933-019-0952-8","article-title":"Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention","volume":"18","author":"Nusca","year":"2019","journal-title":"Cardiovasc Diabetol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/ehjcvp\/pvaa053","article-title":"The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin\u2013angiotensin system","volume":"6","author":"Offringa","year":"2020","journal-title":"Eur. Heart J. - Cardiovasc. Pharmacother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1161\/strokeaha.119.026099","article-title":"Diabetes mellitus is associated with increased risk of ischemic stroke in patients with and without coronary artery disease","volume":"50","author":"Olesen","year":"2019","journal-title":"Stroke"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1167\/iovs.13-11756","article-title":"Adiponectin-induced dilation of isolated porcine retinal arterioles via production of nitric oxide from endothelial cells","volume":"54","author":"Omae","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1161\/strokeaha.115.009371","article-title":"Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study","volume":"46","author":"Overvad","year":"2015","journal-title":"Stroke"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"H1089","DOI":"10.1152\/ajpheart.00615.2024","article-title":"Cardiac energy metabolism in diabetes: emerging therapeutic targets and clinical implications","volume":"328","author":"Panwar","year":"2025","journal-title":"Am. J. Physiology-Heart Circulatory Physiology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1161\/circresaha.116.307708","article-title":"Role of the ACE2\/Angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ. Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnology"},{"key":"B118","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jdiacomp.2015.04.012","article-title":"PPAR\u03b3-PI3K\/AKT-NO signal pathway is involved in cardiomyocyte hypertrophy induced by high glucose and insulin","volume":"29","author":"Peng","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"B119","doi-asserted-by":"publisher","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2337\/db14-0759","article-title":"Diabetic microangiopathy: impact of impaired cerebral vasoreactivity and delayed angiogenesis after permanent middle cerebral artery occlusion on stroke damage and cerebral repair in mice","volume":"64","author":"Poittevin","year":"2015","journal-title":"Diabetes"},{"key":"B122","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/biomedicines12040765","article-title":"Diabetic cardiomyopathy\u2014from basics through diagnosis to treatment","volume":"12","author":"Radzioch","year":"2024","journal-title":"Biomedicines"},{"key":"B123","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.vph.2012.06.004","article-title":"The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes","volume":"57","author":"Ramasamy","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.2337\/dc20-0643","article-title":"Exploring diseases\/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a mendelian randomization analysis highlights tentative relevance of diabetes-related traits","volume":"43","author":"Rao","year":"2020","journal-title":"Diabetes Care"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e84683","DOI":"10.1371\/journal.pone.0084683","article-title":"Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse","volume":"9","author":"Riera","year":"2014","journal-title":"PLoS One"},{"key":"B126","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B127","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4239\/wjd.v12.i5.590","article-title":"Advanced-glycation end-products axis: a contributor to the risk of severe illness from COVID-19 in diabetes patients","volume":"12","author":"Rojas","year":"2021","journal-title":"World J. Diabetes"},{"key":"B128","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/jcdd10080322","article-title":"SGLT2 inhibitors vs. GLP-1 agonists to treat the heart, the kidneys and the brain","volume":"10","author":"Rolek","year":"2023","journal-title":"J. Cardiovasc Dev. Dis."},{"key":"B129","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in COVID-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"695792","DOI":"10.3389\/fmed.2021.695792","article-title":"The diabetic cardiomyopathy: the contributing pathophysiological mechanisms","volume":"8","author":"Salvatore","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1378\/chest.122.4.1412","article-title":"Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats","volume":"122","author":"Sampaio","year":"2002","journal-title":"Chest"},{"key":"B132","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc Med. J."},{"key":"B133","doi-asserted-by":"publisher","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2018.05.005","article-title":"Virus-induced Interferon-\u03b3 causes insulin resistance in skeletal muscle and derails glycemic control in obesity","volume":"49","author":"\u0160estan","year":"2018","journal-title":"Immunity"},{"key":"B135","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1042\/bst20140113","article-title":"Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications?","volume":"42","author":"Shaw","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"B136","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","article-title":"The role of CD36 in cardiovascular disease","volume":"118","author":"Shu","year":"2022","journal-title":"Cardiovasc Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"100549","DOI":"10.1016\/j.xcrm.2022.100549","article-title":"Antiviral agents for the treatment of COVID-19: progress and challenges","volume":"3","author":"Singh","year":"2022","journal-title":"Cell Rep. Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study","volume":"43","author":"Solerte","year":"2020","journal-title":"Diabetes Care"},{"key":"B139","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2213-8587(21)00244-8","article-title":"COVID-19 and metabolic disease: mechanisms and clinical management","volume":"9","author":"Steenblock","year":"2021","journal-title":"lancet Diabetes Endocrinol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/s0925-4439(00)00078-8","article-title":"Influence of diabetes on cardiac nitric oxide synthase expression and activity","volume":"1535","author":"Stockklauser-F\u00e4rber","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"B142","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13098-025-01783-9","article-title":"The role of myocardial fibrosis in the diabetic cardiomyopathy","volume":"17","author":"Sun","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"B143","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/vaccines11030658","article-title":"Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B144","doi-asserted-by":"publisher","first-page":"117404","DOI":"10.1016\/j.lfs.2020.117404","article-title":"Specific inhibition of plasminogen activator inhibitor 1 reduces blood glucose level by lowering TNF-a","volume":"246","author":"Tang","year":"2020","journal-title":"Life Sci."},{"key":"B145","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2022.05.055","article-title":"SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress","volume":"362","author":"Tangos","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.pan.2020.05.015","article-title":"Current evidence on pancreatic involvement in SARS-CoV-2 infection","volume":"20","author":"Thaweerat","year":"2020","journal-title":"Pancreatology"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/01.cir.98.21.2241","article-title":"High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor","volume":"98","author":"Th\u00f6gersen","year":"1998","journal-title":"Circulation"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1421838","DOI":"10.3389\/fendo.2024.1421838","article-title":"Ferroptosis in diabetic cardiomyopathy: from its mechanisms to therapeutic strategies","volume":"15","author":"Tian","year":"2024","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B149","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur. Cardiol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.mce.2015.05.021","article-title":"Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma","volume":"412","author":"Tsukahara","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.2337\/dc20-1551","article-title":"New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K","volume":"43","author":"Unsworth","year":"2020","journal-title":"Diabetes Care"},{"key":"B152","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2337\/diabetes.55.01.06.db05-1026","article-title":"Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand","volume":"55","author":"Vaidyula","year":"2006","journal-title":"Diabetes"},{"key":"B153","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s2213-8587(24)00219-5","article-title":"Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials","volume":"12","author":"Vale","year":"2024","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/s0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B155","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern Med."},{"key":"B156","doi-asserted-by":"publisher","first-page":"108118","DOI":"10.1016\/j.diabres.2020.108118","article-title":"Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed","volume":"162","author":"Wang","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B157","doi-asserted-by":"publisher","first-page":"14336","DOI":"10.1038\/s41598-023-41523-5","article-title":"Long-term multiple metabolic abnormalities among healthy and high-risk people following nonsevere COVID-19","volume":"13","author":"Washirasaksiri","year":"2023","journal-title":"Sci. Rep."},{"key":"B158","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B159","volume-title":"WHO COVID-19 dashboard","year":"2024"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"B161","doi-asserted-by":"publisher","first-page":"772865","DOI":"10.3389\/fendo.2021.772865","article-title":"COVID-19 and diabetes: a comprehensive review of angiotensin converting enzyme 2, mutual effects and pharmacotherapy","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/s2213-2600(20)30076-x","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e001343","DOI":"10.1136\/bmjdrc-2020-001343","article-title":"Clinical characteristics and outcomes of patients with severe COVID-19 with diabetes","volume":"8","author":"Yan","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"B164","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet. Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3760\/cma.j.cn112151-20200312-00193","article-title":"A pathological report of three COVID-19 cases by minimal invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.21037\/atm-21-1291","article-title":"Severe COVID-19 has a distinct phenotype from bacterial sepsis: a retrospective cohort study in deceased patients","volume":"9","author":"Yu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1125246","DOI":"10.3389\/fimmu.2023.1125246","article-title":"The development of COVID-19 treatment","volume":"14","author":"Yuan","year":"2023","journal-title":"Front. Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/nejm200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s13054-020-03255-0","article-title":"Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China","volume":"24","author":"Zeng","year":"2020","journal-title":"Crit. Care"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1375400","DOI":"10.3389\/fcvm.2024.1375400","article-title":"Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy","volume":"11","author":"Zeng","year":"2024","journal-title":"Front. Cardiovasc Med."},{"key":"B172","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3760\/cma.j.issn.0253-3758.2017.05.012","article-title":"Therapeutic effect of combined use of FGF1-loaded nano-liposomes and ultrasound-targeted microbubble destruction technique on treating rats with experimental diabetic cardiomyopathy","volume":"45","author":"Zhang","year":"2017","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"B173","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D\u2010dimer levels on admission to predict in\u2010hospital mortality in patients with COVID\u201019","volume":"18","author":"Zhang","year":"2020","journal-title":"J. thrombosis haemostasis"},{"key":"B174","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/circulationaha.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab."},{"key":"B177","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B178","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front. Med."},{"key":"B179","doi-asserted-by":"crossref","DOI":"10.1101\/2020.04.09.20059626","volume-title":"Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19","author":"Zuo","year":"2020"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1683159\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:17:50Z","timestamp":1760329070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1683159\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":179,"alternative-id":["10.3389\/fphar.2025.1683159"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1683159","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"article-number":"1683159"}}